Home » Topics » Regulatory » Health Canada

Health Canada
RSS

NDS for insomnia therapy accepted for review by Health Canada

Feb. 23, 2012

Roche obtains Canadian approval for Zelboraf

Feb. 17, 2012

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

RedHill Biopharma clear to conduct advanced-stage RHB-102 trial

Feb. 15, 2012

RedHill receives approval from Health Canada to begin RHB-102 trial

Feb. 9, 2012

Health Canada approves ipilimumab

Feb. 8, 2012

Health Canada accepts CIP-Isotretinoin submission for review

Jan. 31, 2012

Health Canada grants priority review status to Cinryze

Jan. 16, 2012

Abilify approved in Canada for use in new patient population

Dec. 21, 2011

Health Canada approves treatment for iron deficiency anemia in CKD

Dec. 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 26, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 26, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...